Copyright Reports & Markets. All rights reserved.

Global Automated DNA and RNA Synthesizer Market Research Report 2021

Buy now

1 Automated DNA and RNA Synthesizer Market Overview

  • 1.1 Product Overview and Scope of Automated DNA and RNA Synthesizer
  • 1.2 Automated DNA and RNA Synthesizer Segment by Type
    • 1.2.1 Global Automated DNA and RNA Synthesizer Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 10-Column DNA and RNA Synthesizer
    • 1.2.3 12-Column DNA and RNA Synthesizer
    • 1.2.4 96-Column DNA and RNA Synthesizer
  • 1.3 Automated DNA and RNA Synthesizer Segment by Application
    • 1.3.1 Automated DNA and RNA Synthesizer Sales Comparison by Application: (2021-2027)
    • 1.3.2 Medical
    • 1.3.3 Laboratory
    • 1.3.4 Biochemistry Research Institution
  • 1.4 Global Automated DNA and RNA Synthesizer Market Size Estimates and Forecasts
    • 1.4.1 Global Automated DNA and RNA Synthesizer Revenue 2016-2027
    • 1.4.2 Global Automated DNA and RNA Synthesizer Sales 2016-2027
    • 1.4.3 Automated DNA and RNA Synthesizer Market Size by Region: 2016 Versus 2021 Versus 2027

2 Automated DNA and RNA Synthesizer Market Competition by Manufacturers

  • 2.1 Global Automated DNA and RNA Synthesizer Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Automated DNA and RNA Synthesizer Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Automated DNA and RNA Synthesizer Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Automated DNA and RNA Synthesizer Manufacturing Sites, Area Served, Product Type
  • 2.5 Automated DNA and RNA Synthesizer Market Competitive Situation and Trends
    • 2.5.1 Automated DNA and RNA Synthesizer Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Automated DNA and RNA Synthesizer Players Market Share by Revenue
    • 2.5.3 Global Automated DNA and RNA Synthesizer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Automated DNA and RNA Synthesizer Retrospective Market Scenario by Region

  • 3.1 Global Automated DNA and RNA Synthesizer Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Automated DNA and RNA Synthesizer Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Automated DNA and RNA Synthesizer Market Facts & Figures by Country
    • 3.3.1 North America Automated DNA and RNA Synthesizer Sales by Country
    • 3.3.2 North America Automated DNA and RNA Synthesizer Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Automated DNA and RNA Synthesizer Market Facts & Figures by Country
    • 3.4.1 Europe Automated DNA and RNA Synthesizer Sales by Country
    • 3.4.2 Europe Automated DNA and RNA Synthesizer Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Automated DNA and RNA Synthesizer Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Automated DNA and RNA Synthesizer Sales by Region
    • 3.5.2 Asia Pacific Automated DNA and RNA Synthesizer Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Automated DNA and RNA Synthesizer Market Facts & Figures by Country
    • 3.6.1 Latin America Automated DNA and RNA Synthesizer Sales by Country
    • 3.6.2 Latin America Automated DNA and RNA Synthesizer Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Automated DNA and RNA Synthesizer Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Automated DNA and RNA Synthesizer Sales by Country
    • 3.7.2 Middle East and Africa Automated DNA and RNA Synthesizer Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Automated DNA and RNA Synthesizer Historic Market Analysis by Type

  • 4.1 Global Automated DNA and RNA Synthesizer Sales Market Share by Type (2016-2021)
  • 4.2 Global Automated DNA and RNA Synthesizer Revenue Market Share by Type (2016-2021)
  • 4.3 Global Automated DNA and RNA Synthesizer Price by Type (2016-2021)

5 Global Automated DNA and RNA Synthesizer Historic Market Analysis by Application

  • 5.1 Global Automated DNA and RNA Synthesizer Sales Market Share by Application (2016-2021)
  • 5.2 Global Automated DNA and RNA Synthesizer Revenue Market Share by Application (2016-2021)
  • 5.3 Global Automated DNA and RNA Synthesizer Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 General Electric
    • 6.1.1 General Electric Corporation Information
    • 6.1.2 General Electric Description and Business Overview
    • 6.1.3 General Electric Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 General Electric Product Portfolio
    • 6.1.5 General Electric Recent Developments/Updates
  • 6.2 Thermo Fisher Scientific
    • 6.2.1 Thermo Fisher Scientific Corporation Information
    • 6.2.2 Thermo Fisher Scientific Description and Business Overview
    • 6.2.3 Thermo Fisher Scientific Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Thermo Fisher Scientific Product Portfolio
    • 6.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 6.3 Tekna Plasma Systems
    • 6.3.1 Tekna Plasma Systems Corporation Information
    • 6.3.2 Tekna Plasma Systems Description and Business Overview
    • 6.3.3 Tekna Plasma Systems Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Tekna Plasma Systems Product Portfolio
    • 6.3.5 Tekna Plasma Systems Recent Developments/Updates
  • 6.4 BioAutomation Corporation
    • 6.4.1 BioAutomation Corporation Corporation Information
    • 6.4.2 BioAutomation Corporation Description and Business Overview
    • 6.4.3 BioAutomation Corporation Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 BioAutomation Corporation Product Portfolio
    • 6.4.5 BioAutomation Corporation Recent Developments/Updates
  • 6.5 Polygen GmbH
    • 6.5.1 Polygen GmbH Corporation Information
    • 6.5.2 Polygen GmbH Description and Business Overview
    • 6.5.3 Polygen GmbH Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Polygen GmbH Product Portfolio
    • 6.5.5 Polygen GmbH Recent Developments/Updates
  • 6.6 GlobalSpec
    • 6.6.1 GlobalSpec Corporation Information
    • 6.6.2 GlobalSpec Description and Business Overview
    • 6.6.3 GlobalSpec Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 GlobalSpec Product Portfolio
    • 6.6.5 GlobalSpec Recent Developments/Updates
  • 6.7 Biolytic Lab Performance
    • 6.6.1 Biolytic Lab Performance Corporation Information
    • 6.6.2 Biolytic Lab Performance Description and Business Overview
    • 6.6.3 Biolytic Lab Performance Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Biolytic Lab Performance Product Portfolio
    • 6.7.5 Biolytic Lab Performance Recent Developments/Updates
  • 6.8 Beckman Coulter
    • 6.8.1 Beckman Coulter Corporation Information
    • 6.8.2 Beckman Coulter Description and Business Overview
    • 6.8.3 Beckman Coulter Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Beckman Coulter Product Portfolio
    • 6.8.5 Beckman Coulter Recent Developments/Updates
  • 6.9 ACTGene
    • 6.9.1 ACTGene Corporation Information
    • 6.9.2 ACTGene Description and Business Overview
    • 6.9.3 ACTGene Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 ACTGene Product Portfolio
    • 6.9.5 ACTGene Recent Developments/Updates
  • 6.10 Precision System Science
    • 6.10.1 Precision System Science Corporation Information
    • 6.10.2 Precision System Science Description and Business Overview
    • 6.10.3 Precision System Science Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Precision System Science Product Portfolio
    • 6.10.5 Precision System Science Recent Developments/Updates
  • 6.11 CSBio
    • 6.11.1 CSBio Corporation Information
    • 6.11.2 CSBio Automated DNA and RNA Synthesizer Description and Business Overview
    • 6.11.3 CSBio Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 CSBio Product Portfolio
    • 6.11.5 CSBio Recent Developments/Updates
  • 6.12 Genscript Biotech
    • 6.12.1 Genscript Biotech Corporation Information
    • 6.12.2 Genscript Biotech Automated DNA and RNA Synthesizer Description and Business Overview
    • 6.12.3 Genscript Biotech Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Genscript Biotech Product Portfolio
    • 6.12.5 Genscript Biotech Recent Developments/Updates
  • 6.13 Protein Technologies
    • 6.13.1 Protein Technologies Corporation Information
    • 6.13.2 Protein Technologies Automated DNA and RNA Synthesizer Description and Business Overview
    • 6.13.3 Protein Technologies Automated DNA and RNA Synthesizer Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Protein Technologies Product Portfolio
    • 6.13.5 Protein Technologies Recent Developments/Updates

7 Automated DNA and RNA Synthesizer Manufacturing Cost Analysis

  • 7.1 Automated DNA and RNA Synthesizer Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Automated DNA and RNA Synthesizer
  • 7.4 Automated DNA and RNA Synthesizer Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Automated DNA and RNA Synthesizer Distributors List
  • 8.3 Automated DNA and RNA Synthesizer Customers

9 Automated DNA and RNA Synthesizer Market Dynamics

  • 9.1 Automated DNA and RNA Synthesizer Industry Trends
  • 9.2 Automated DNA and RNA Synthesizer Growth Drivers
  • 9.3 Automated DNA and RNA Synthesizer Market Challenges
  • 9.4 Automated DNA and RNA Synthesizer Market Restraints

10 Global Market Forecast

  • 10.1 Automated DNA and RNA Synthesizer Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Automated DNA and RNA Synthesizer by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Automated DNA and RNA Synthesizer by Type (2022-2027)
  • 10.2 Automated DNA and RNA Synthesizer Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Automated DNA and RNA Synthesizer by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Automated DNA and RNA Synthesizer by Application (2022-2027)
  • 10.3 Automated DNA and RNA Synthesizer Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Automated DNA and RNA Synthesizer by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Automated DNA and RNA Synthesizer by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    10-Column DNA and RNA Synthesizer
    12-Column DNA and RNA Synthesizer
    96-Column DNA and RNA Synthesizer

    Segment by Application
    Medical
    Laboratory
    Biochemistry Research Institution

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    General Electric
    Thermo Fisher Scientific
    Tekna Plasma Systems
    BioAutomation Corporation
    Polygen GmbH
    GlobalSpec
    Biolytic Lab Performance
    Beckman Coulter
    ACTGene
    Precision System Science
    CSBio
    Genscript Biotech
    Protein Technologies

    Buy now